Cargando…

Nanomedicine Approaches for Corneal Diseases

Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaurasia, Shyam S., Lim, Rayne R., Lakshminarayanan, Rajamani, Mohan, Rajiv R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493512/ https://www.ncbi.nlm.nih.gov/pubmed/25941990 http://dx.doi.org/10.3390/jfb6020277

Ejemplares similares

NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
por: Lim, Rayne R., et al.
Publicado: (2020)

Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases
por: Mahaling, Binapani, et al.
Publicado: (2023)

Collagen matrix perturbations in corneal stroma of Ossabaw mini pigs with type 2 diabetes
por: Sinha, Nishant R., et al.
Publicado: (2021)

ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis
por: Lim, Rayne R., et al.
Publicado: (2016)

Gene editing for corneal disease management
por: Raikwar, Sudhanshu P, et al.
Publicado: (2016)

pH Induced Conformational Transitions in the Transforming Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants
por: Murugan, Elavazhagan, et al.
Publicado: (2016)

Hevin Plays a Pivotal Role in Corneal Wound Healing
por: Chaurasia, Shyam S., et al.
Publicado: (2013)

Correction: Hevin Plays a Pivotal Role in Corneal Wound Healing
por: Chaurasia, Shyam S., et al.
Publicado: (2014)

Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients
por: Anandalakshmi, Venkatraman, et al.
Publicado: (2017)

Corneal Regeneration Using Gene Therapy Approaches
por: Sarkar, Subhradeep, et al.
Publicado: (2023)

Effect of Fibrin Glue on the Biomechanical Properties of Human Descemet's Membrane
por: Chaurasia, Shyam S., et al.
Publicado: (2012)

Celastrol-based nanomedicine promotes corneal allograft survival
por: Li, Zhanrong, et al.
Publicado: (2021)

Young Ossabaw Pigs Fed a Western Diet Exhibit Early Signs of Diabetic Retinopathy
por: Lim, Rayne R., et al.
Publicado: (2018)

New Approaches in Nanomedicine for Ischemic Stroke
por: Correa-Paz, Clara, et al.
Publicado: (2021)

New Insights into RPE-Photoreceptor Complex Ultrastructure using Focused Ion Beam-Scanning Election Microscopy (FIB-SEM)
por: Low, Shermaine W.Y., et al.
Publicado: (2023)

Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo
por: Gupta, Suneel, et al.
Publicado: (2018)

Nanomedicine for Respiratory Diseases
por: Bahadori, Moslem, et al.
Publicado: (2012)

Nanomedicine as an emerging approach against intracellular pathogens
por: Armstead, Andrea L, et al.
Publicado: (2011)

Nanomedicine approaches for treatment of hematologic and oncologic malignancies
por: Nteli, Polyxeni, et al.
Publicado: (2022)

Approved Nanomedicine against Diseases
por: Jia, Yuanchao, et al.
Publicado: (2023)

Selective Induction of Intrinsic Apoptosis in Retinoblastoma Cells by Novel Cationic Antimicrobial Dodecapeptides
por: Suresh Babu, Vishnu, et al.
Publicado: (2022)

Fullerenols as a New Therapeutic Approach in Nanomedicine
por: Grebowski, Jacek, et al.
Publicado: (2013)

Nanomedicine in coronary artery disease
por: Ambesh, Paurush, et al.
Publicado: (2017)

Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
por: Durymanov, Mikhail O, et al.
Publicado: (2015)

Protein corona: a new approach for nanomedicine design
por: Nguyen, Van Hong, et al.
Publicado: (2017)

Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016)

Heterojunction Nanomedicine
por: Pan, Chao, et al.
Publicado: (2022)

Ocular Nanomedicine
por: Tang, Zhimin, et al.
Publicado: (2022)

Polymeric nanomedicines for the treatment of hepatic diseases
por: Luo, Feixiang, et al.
Publicado: (2022)

Ferritin-based nanomedicine for disease treatment
por: Zhu, Yuanjun, et al.
Publicado: (2023)

The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
por: Chaurasia, Shyam S., et al.
Publicado: (2018)

Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
por: Khiev, Dawin, et al.
Publicado: (2021)

3D printing technology in nanomedicine
por: Ahmad, Nabeel, et al.
Publicado: (2019)

Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics
por: Alimardani, Vahid, et al.
Publicado: (2021)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)

Current approaches of nanomedicines in the market and various stage of clinical translation
por: Shan, Xiaoting, et al.
Publicado: (2022)

The advances in nanomedicine for bone and cartilage repair
por: Qiao, Kai, et al.
Publicado: (2022)

Update on the genetics of corneal endothelial dystrophies
por: Kannabiran, Chitra, et al.
Publicado: (2022)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
por: Manners, Natasha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6usp1a18foulicplkgd9q34p5